Clinical Glutathione

Basic Information

Product Label

Full Name: Clinical Glutathione

Brand: EuroMedica ®

Product Type: Non-Nutrient/Non-Botanical

Physical State: Tablet or Pill

UPC/SKU: 3 67703 73706 1

Product Version Code: JC 34 91 + 3(5,6)EP BX73706.05

Contact Information

Manufactured by a cGMP compliant facility exclusively for

Name: EuroMedica

Address:955 Challenger Drive, Green Bay, WI, 54311

Phone: 866-842-7256

Email: EuroMedicaUSA.com

Types: Distributor

Product Details

Net Contents

60 Slow Melt Tablet(s)(60 Slow Melt Tablet(s))

Serving Sizes

Unit:Slow Melt Tablet(s)

Quantity:2 - 2

Daily Servings:1 - 1

Target Groups

VeganVegetarianAdult (18 - 50 Years)Gluten FreeDairy FreeSugar Free

Servings Per Container

Ingredients & Nutrition

L-Glutathione

non-nutrient/non-botanical

Notes: reduced active form

Amount: 300 mg

Serving Size: 2 Slow Melt Tablet(s)

Adults and children 4 or more years of age: % (Daily Value (DV) Not Established)

Group: Glutathione

HPMC

other

Group: Hypromellose

Also known as: Hydroxypropylmethylcellulose, Hydroxypropyl Methyl Cellulose, Hydroxypropyl Methylcellulose, Hypromellose

Maltitol

non-nutrient/non-botanical

Group: Maltitol

UNII Code: D65DG142WK

Pomegranate (Punica granatum) fruit extract

botanical

Group: Pomegranate

Setria

non-nutrient/non-botanical

Group: Glutathione

Also known as: reduced L-Glutathione, L-Glutathione

UNII Code: 0

Vanilla flavor

botanical

Group: Vanilla

UNII Code: Q74T35078H

Vegetable Source Magnesium Stearate

other

Group: Magnesium stearate

Product Statements

Formulation re: Other

Proven active form

Brand IP Statement(s) re: (c), (TM), (SM)

Sublinthion Patented protection system

Formula re: Contains

Patented, reduced oral glutathione for vital support

Formulation re: Other

230% greater blood ratios

Formulation re: Other

Proven stability 230% improvement

FDA Statement of Identity

Dietary Supplement

Formulation re: Vegetarian/Vegan

Vegan

Formulation re: Does NOT Contain

Non-GMO

FDA Disclaimer Statement

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements: All Other Content

Product of France

Brand IP Statement(s) re: (c), (TM), (SM)

French patent #FR2972327

Formulation re: Other

In a published human study, Clinical Glutathione with Sublinthion reported a 230% improvement in healthy glutathione ratios compared to unprotected glutathione.

General Statements: All Other Content

Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation. Blood GSH/GSSG ratio compared to unprotected glutathione

Formulation re: Does NOT Contain

No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.

Suggested/Recommended/Usage/Directions

Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.